[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Imatinib Drugs Market Research Report 2021-2025

February 2021 | 152 pages | ID: G1331435F7CEEN
9Dimen Research

US$ 2,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Imatinib, sold under the brand name Gleevec among others, is an oral chemotherapy medication used to treat cancer. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Imatinib Drugs Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Imatinib Drugs market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Imatinib Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Apotex Inc.
Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Capsules
Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Imatinib Drugs for each application, including-
Hospitals
Drug Stores
PART I IMATINIB DRUGS INDUSTRY OVERVIEW

CHAPTER ONE IMATINIB DRUGS INDUSTRY OVERVIEW

1.1 Imatinib Drugs Definition
1.2 Imatinib Drugs Classification Analysis
  1.2.1 Imatinib Drugs Main Classification Analysis
  1.2.2 Imatinib Drugs Main Classification Share Analysis
1.3 Imatinib Drugs Application Analysis
  1.3.1 Imatinib Drugs Main Application Analysis
  1.3.2 Imatinib Drugs Main Application Share Analysis
1.4 Imatinib Drugs Industry Chain Structure Analysis
1.5 Imatinib Drugs Industry Development Overview
  1.5.1 Imatinib Drugs Product History Development Overview
  1.5.1 Imatinib Drugs Product Market Development Overview
1.6 Imatinib Drugs Global Market Comparison Analysis
  1.6.1 Imatinib Drugs Global Import Market Analysis
  1.6.2 Imatinib Drugs Global Export Market Analysis
  1.6.3 Imatinib Drugs Global Main Region Market Analysis
  1.6.4 Imatinib Drugs Global Market Comparison Analysis
  1.6.5 Imatinib Drugs Global Market Development Trend Analysis

CHAPTER TWO IMATINIB DRUGS UP AND DOWN STREAM INDUSTRY ANALYSIS

2.1 Upstream Raw Materials Analysis
  2.1.1 Proportion of Manufacturing Cost
  2.1.2 Manufacturing Cost Structure of Imatinib Drugs Analysis
2.2 Down Stream Market Analysis
  2.2.1 Down Stream Market Analysis
  2.2.2 Down Stream Demand Analysis
  2.2.3 Down Stream Market Trend Analysis

PART II ASIA IMATINIB DRUGS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER THREE ASIA IMATINIB DRUGS MARKET ANALYSIS

3.1 Asia Imatinib Drugs Product Development History
3.2 Asia Imatinib Drugs Competitive Landscape Analysis
3.3 Asia Imatinib Drugs Market Development Trend

CHAPTER FOUR 2016-2021 ASIA IMATINIB DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

4.1 2016-2021 Imatinib Drugs Production Overview
4.2 2016-2021 Imatinib Drugs Production Market Share Analysis
4.3 2016-2021 Imatinib Drugs Demand Overview
4.4 2016-2021 Imatinib Drugs Supply Demand and Shortage
4.5 2016-2021 Imatinib Drugs Import Export Consumption
4.6 2016-2021 Imatinib Drugs Cost Price Production Value Gross Margin

CHAPTER FIVE ASIA IMATINIB DRUGS KEY MANUFACTURERS ANALYSIS

5.1 Company A
  5.1.1 Company Profile
  5.1.2 Product Picture and Specification
  5.1.3 Product Application Analysis
  5.1.4 Capacity Production Price Cost Production Value
  5.1.5 Contact Information
5.2 Company B
  5.2.1 Company Profile
  5.2.2 Product Picture and Specification
  5.2.3 Product Application Analysis
  5.2.4 Capacity Production Price Cost Production Value
  5.2.5 Contact Information
5.3 Company C
  5.3.1 Company Profile
  5.3.2 Product Picture and Specification
  5.3.3 Product Application Analysis
  5.3.4 Capacity Production Price Cost Production Value
  5.3.5 Contact Information
5.4 Company D
  5.4.1 Company Profile
  5.4.2 Product Picture and Specification
  5.4.3 Product Application Analysis
  5.4.4 Capacity Production Price Cost Production Value
  5.4.5 Contact Information

CHAPTER SIX ASIA IMATINIB DRUGS INDUSTRY DEVELOPMENT TREND

6.1 2021-2025 Imatinib Drugs Production Overview
6.2 2021-2025 Imatinib Drugs Production Market Share Analysis
6.3 2021-2025 Imatinib Drugs Demand Overview
6.4 2021-2025 Imatinib Drugs Supply Demand and Shortage
6.5 2021-2025 Imatinib Drugs Import Export Consumption
6.6 2021-2025 Imatinib Drugs Cost Price Production Value Gross Margin

PART III NORTH AMERICAN IMATINIB DRUGS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER SEVEN NORTH AMERICAN IMATINIB DRUGS MARKET ANALYSIS

7.1 North American Imatinib Drugs Product Development History
7.2 North American Imatinib Drugs Competitive Landscape Analysis
7.3 North American Imatinib Drugs Market Development Trend

CHAPTER EIGHT 2016-2021 NORTH AMERICAN IMATINIB DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

8.1 2016-2021 Imatinib Drugs Production Overview
8.2 2016-2021 Imatinib Drugs Production Market Share Analysis
8.3 2016-2021 Imatinib Drugs Demand Overview
8.4 2016-2021 Imatinib Drugs Supply Demand and Shortage
8.5 2016-2021 Imatinib Drugs Import Export Consumption
8.6 2016-2021 Imatinib Drugs Cost Price Production Value Gross Margin

CHAPTER NINE NORTH AMERICAN IMATINIB DRUGS KEY MANUFACTURERS ANALYSIS

9.1 Company A
  9.1.1 Company Profile
  9.1.2 Product Picture and Specification
  9.1.3 Product Application Analysis
  9.1.4 Capacity Production Price Cost Production Value
  9.1.5 Contact Information
9.2 Company B
  9.2.1 Company Profile
  9.2.2 Product Picture and Specification
  9.2.3 Product Application Analysis
  9.2.4 Capacity Production Price Cost Production Value
  9.2.5 Contact Information

CHAPTER TEN NORTH AMERICAN IMATINIB DRUGS INDUSTRY DEVELOPMENT TREND

10.1 2021-2025 Imatinib Drugs Production Overview
10.2 2021-2025 Imatinib Drugs Production Market Share Analysis
10.3 2021-2025 Imatinib Drugs Demand Overview
10.4 2021-2025 Imatinib Drugs Supply Demand and Shortage
10.5 2021-2025 Imatinib Drugs Import Export Consumption
10.6 2021-2025 Imatinib Drugs Cost Price Production Value Gross Margin

PART IV EUROPE IMATINIB DRUGS INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER ELEVEN EUROPE IMATINIB DRUGS MARKET ANALYSIS

11.1 Europe Imatinib Drugs Product Development History
11.2 Europe Imatinib Drugs Competitive Landscape Analysis
11.3 Europe Imatinib Drugs Market Development Trend

CHAPTER TWELVE 2016-2021 EUROPE IMATINIB DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

12.1 2016-2021 Imatinib Drugs Production Overview
12.2 2016-2021 Imatinib Drugs Production Market Share Analysis
12.3 2016-2021 Imatinib Drugs Demand Overview
12.4 2016-2021 Imatinib Drugs Supply Demand and Shortage
12.5 2016-2021 Imatinib Drugs Import Export Consumption
12.6 2016-2021 Imatinib Drugs Cost Price Production Value Gross Margin

CHAPTER THIRTEEN EUROPE IMATINIB DRUGS KEY MANUFACTURERS ANALYSIS

13.1 Company A
  13.1.1 Company Profile
  13.1.2 Product Picture and Specification
  13.1.3 Product Application Analysis
  13.1.4 Capacity Production Price Cost Production Value
  13.1.5 Contact Information
13.2 Company B
  13.2.1 Company Profile
  13.2.2 Product Picture and Specification
  13.2.3 Product Application Analysis
  13.2.4 Capacity Production Price Cost Production Value
  13.2.5 Contact Information

CHAPTER FOURTEEN EUROPE IMATINIB DRUGS INDUSTRY DEVELOPMENT TREND

14.1 2021-2025 Imatinib Drugs Production Overview
14.2 2021-2025 Imatinib Drugs Production Market Share Analysis
14.3 2021-2025 Imatinib Drugs Demand Overview
14.4 2021-2025 Imatinib Drugs Supply Demand and Shortage
14.5 2021-2025 Imatinib Drugs Import Export Consumption
14.6 2021-2025 Imatinib Drugs Cost Price Production Value Gross Margin

PART V IMATINIB DRUGS MARKETING CHANNELS AND INVESTMENT FEASIBILITY

CHAPTER FIFTEEN IMATINIB DRUGS MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS

15.1 Imatinib Drugs Marketing Channels Status
15.2 Imatinib Drugs Marketing Channels Characteristic
15.3 Imatinib Drugs Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS

16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

CHAPTER SEVENTEEN IMATINIB DRUGS NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS

17.1 Imatinib Drugs Market Analysis
17.2 Imatinib Drugs Project SWOT Analysis
17.3 Imatinib Drugs New Project Investment Feasibility Analysis

PART VI GLOBAL IMATINIB DRUGS INDUSTRY CONCLUSIONS

CHAPTER EIGHTEEN 2016-2021 GLOBAL IMATINIB DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

18.1 2016-2021 Imatinib Drugs Production Overview
18.2 2016-2021 Imatinib Drugs Production Market Share Analysis
18.3 2016-2021 Imatinib Drugs Demand Overview
18.4 2016-2021 Imatinib Drugs Supply Demand and Shortage
18.5 2016-2021 Imatinib Drugs Import Export Consumption
18.6 2016-2021 Imatinib Drugs Cost Price Production Value Gross Margin

CHAPTER NINETEEN GLOBAL IMATINIB DRUGS INDUSTRY DEVELOPMENT TREND

19.1 2021-2025 Imatinib Drugs Production Overview
19.2 2021-2025 Imatinib Drugs Production Market Share Analysis
19.3 2021-2025 Imatinib Drugs Demand Overview
19.4 2021-2025 Imatinib Drugs Supply Demand and Shortage
19.5 2021-2025 Imatinib Drugs Import Export Consumption
19.6 2021-2025 Imatinib Drugs Cost Price Production Value Gross Margin

CHAPTER TWENTY GLOBAL IMATINIB DRUGS INDUSTRY RESEARCH CONCLUSIONS


More Publications